Diet- and Genetically-Induced Obesity Differentially Affect the Fecal Microbiome and Metabolome in Apc1638N Mice
暂无分享,去创建一个
L. Iyer | Sang-Woon Choi | J. Mason | L. Parnell | A. Greenberg | M. Obin | A. Kane | J. Selhub | Zhenhua Liu | A. Pfalzer | J. Crott | A. Tai | T. A. Bowman | L. Paul | C. Chen | P. Nesbeth | Anna C. Pfalzer
[1] T. Whiteside,et al. Immunoregulatory activity of adenosine and its role in human cancer progression , 2014, Expert review of clinical immunology.
[2] Patrick D Schloss,et al. Structure of the gut microbiome following colonization with human feces determines colonic tumor burden , 2014, Microbiome.
[3] A. Jemal,et al. Colorectal cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[4] L. Eusebi,et al. Mechanisms of obesity-induced gastrointestinal neoplasia. , 2014, Gastroenterology.
[5] J. Wischhusen,et al. Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion. , 2014, American journal of translational research.
[6] Timothy J. Laurent,et al. A Taxonomic Signature of Obesity in the Microbiome? Getting to the Guts of the Matter , 2014, PloS one.
[7] J. Goedert,et al. Human gut microbiome and risk for colorectal cancer. , 2013, Journal of the National Cancer Institute.
[8] L. Antonioli,et al. Immunity, inflammation and cancer: a leading role for adenosine , 2013, Nature Reviews Cancer.
[9] J. Petrosino,et al. The Gut Microbiome Modulates Colon Tumorigenesis , 2013, mBio.
[10] B. Kuster,et al. High-fat diet alters gut microbiota physiology in mice , 2013, The ISME Journal.
[11] Amy M. Sheflin,et al. Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults , 2013, PloS one.
[12] S. Snapper,et al. Characterization of Adherent Bacteroidales from Intestinal Biopsies of Children and Young Adults with Inflammatory Bowel Disease , 2013, PLoS ONE.
[13] U. Flögel,et al. Deletion of CD73 promotes dyslipidemia and intramyocellular lipid accumulation in muscle of mice , 2013, Archives of physiology and biochemistry.
[14] C. Mantzoros,et al. Abdominal Obesity, Independent from Caloric Intake, Accounts for the Development of Intestinal Tumors in Apc1638N/+ Female Mice , 2013, Cancer Prevention Research.
[15] R. Sandler,et al. Fusobacterium Is Associated with Colorectal Adenomas , 2013, PloS one.
[16] B. Schwartz,et al. Mechanisms linking obesity, inflammation and altered metabolism to colon carcinogenesis , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[17] H. F. Carvalho,et al. RETRACTED: Obesity-induced increase in tumor necrosis factor-α leads to development of colon cancer in mice. , 2012, Gastroenterology.
[18] Jian Ye,et al. Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction , 2012, BMC Bioinformatics.
[19] David S. Wishart,et al. MetaboAnalyst 2.0—a comprehensive server for metabolomic data analysis , 2012, Nucleic Acids Res..
[20] F. Bushman,et al. Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.
[21] Sang-Woon Choi,et al. Combined inadequacies of multiple B vitamins amplify colonic Wnt signaling and promote intestinal tumorigenesis in BAT‐LacZ×Apc1638N mice , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] Liping Zhao,et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers , 2011, The ISME Journal.
[23] C. Huttenhower,et al. Metagenomic biomarker discovery and explanation , 2011, Genome Biology.
[24] T. Hudcovic,et al. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition , 2011, Clinical and experimental immunology.
[25] F. Da Settimo,et al. The Blockade of Adenosine Deaminase Ameliorates Chronic Experimental Colitis through the Recruitment of Adenosine A2A and A3 Receptors , 2010, Journal of Pharmacology and Experimental Therapeutics.
[26] Anne M. Evans,et al. Organization of GC/MS and LC/MS metabolomics data into chemical libraries , 2010, J. Cheminformatics.
[27] William A. Walters,et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample , 2010, Proceedings of the National Academy of Sciences.
[28] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[29] Zaid Abdo,et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas , 2010, Gut microbes.
[30] P. Turnbaugh,et al. The core gut microbiome, energy balance and obesity , 2009, The Journal of physiology.
[31] Corey D. DeHaven,et al. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.
[32] Lining Guo,et al. Untargeted Metabolomic Profiling as an Evaluative Tool of Fenofibrate-Induced Toxicology in Fischer 344 Male Rats , 2009, Toxicologic pathology.
[33] S. Colgan,et al. Contribution of Adenosine A2B Receptors to Inflammatory Parameters of Experimental Colitis 1 , 2009, The Journal of Immunology.
[34] G. Rogler,et al. Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice. , 2009, The Journal of nutrition.
[35] R. Kucherlapati,et al. Obesity enhances gastrointestinal tumorigenesis in Apc-mutant mice , 2008, International Journal of Obesity.
[36] T. Barrett,et al. Therapeutic benefit of pentostatin in severe IL‐10−/− Colitis , 2008, Inflammatory bowel diseases.
[37] L. Fulton,et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. , 2008, Cell host & microbe.
[38] F. Da Settimo,et al. Inhibition of Adenosine Deaminase Attenuates Inflammation in Experimental Colitis , 2007, Journal of Pharmacology and Experimental Therapeutics.
[39] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[40] Eoin L. Brodie,et al. Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.
[41] C. Moskaluk,et al. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. , 2005, Gastroenterology.
[42] E. Calle,et al. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.
[43] C. Szabó,et al. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis. , 2003, European journal of pharmacology.
[44] G. Fantuzzi,et al. IL-1β-converting enzyme (caspase-1) in intestinal inflammation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[45] G. Hartmann,et al. Adenosine kinase inhibitor GP515 improves experimental colitis in mice. , 2000, The Journal of pharmacology and experimental therapeutics.
[46] R Fodde,et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[47] K P Hummel,et al. Diabetes, a New Mutafton in the Mouse , 1966, Science.
[48] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[49] G. Fantuzzi,et al. IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Hardcastle,et al. Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.